← ABBOTT LABORATORIES

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $20.9b
$27.4b +31.35%
$30.6b +11.64%
$31.9b +4.34%
$34.6b +8.48%
$43.1b +24.47%
$43.7b +1.34%
$40.1b -8.12%
$42.0b +4.59%
$44.3b +5.67%
$46.6b +5.09%
Cost of Revenue $9.0b
$12.3b +36.71%
$12.7b +2.99%
$13.2b +4.13%
$15.0b +13.39%
$18.5b +23.56%
$19.1b +3.26%
$18.0b -6.10%
$18.7b +4.07%
$19.3b +3.28%
$20.2b +4.62%
Cost of products sold, excluding amortization of intangible assets $9.0b
$12.3b +36.71%
$12.7b +2.99%
$13.2b +4.13%
$15.0b +13.39%
$18.5b +23.56%
$19.1b +3.26%
$18.0b -6.10%
$18.7b +4.07%
$19.3b +3.28%
—
Gross Profit (Calculated) $11.8b
$15.1b +27.26%
$17.9b +18.73%
$18.7b +4.48%
$19.6b +4.99%
$24.5b +25.16%
$24.5b -0.11%
$22.1b -9.70%
$23.2b +5.01%
$25.0b +7.59%
—
Research and Development Expense $1.4b $2.2b $2.3b $2.4b $2.4b $2.7b $2.9b $2.7b $2.8b $2.9b $3.2b
Selling, General and Administrative Expense $6.7b $9.1b $9.7b $9.8b $9.7b $11.3b $11.2b $10.9b $11.7b $12.3b $13.9b
Amortization of Intangible Assets $550.0m $2.0b $2.2b $1.9b $2.1b $2.0b $2.0b $2.0b $1.9b $1.7b —
Operating expenses:
Operating Income (Loss) $3.2b
$1.7b -45.81%
$3.6b +111.47%
$4.5b +24.16%
$5.4b +18.20%
$8.4b +57.27%
$8.4b -0.75%
$6.5b -22.53%
$6.8b +5.36%
$8.1b +17.99%
$7.3b -8.78%
Interest Expense $431.0m $904.0m $826.0m $670.0m $546.0m $533.0m $558.0m $637.0m $559.0m $493.0m $608.0m
Interest income ($99.0m) ($124.0m) ($105.0m) ($94.0m) ($46.0m) ($43.0m) ($183.0m) ($385.0m) ($344.0m) ($308.0m) $335.0m
Foreign Currency Transaction Gain (Loss), before Tax ($495.0m) $34.0m ($28.0m) ($7.0m) $8.0m ($1.0m) ($2.0m) ($41.0m) $27.0m $50.0m —
Other Nonoperating Income (Expense) ($945.0m) $1.3b $139.0m $191.0m $103.0m $277.0m $321.0m $479.0m $376.0m $548.0m —
Earnings before Taxes $1.4b $2.2b $2.9b $4.1b $5.0b $8.2b $8.3b $6.7b $7.0b $8.5b —
Income (Loss) from Continuing Operations before Income Taxes, Domestic $306.0m $308.0m ($430.0m) $889.0m $1.6b $3.3b $3.7b $1.2b $947.0m $1.8b $7.5b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1.4b $2.2b $2.9b $4.1b $5.0b $8.2b $8.3b $6.7b $7.0b $8.5b $7.5b
Current Income Tax Expense (Benefit) $477.0m $2.8b ($206.0m) $881.0m $605.0m $1.6b $2.0b $1.4b $1.6b $1.5b $2.1b
Income Tax Expense (Benefit) $350.0m $1.9b $539.0m $390.0m $497.0m $1.1b $1.4b $941.0m ($6.4b) $1.9b $2.1b
Net Earnings $1.4b
$477.0m -65.93%
$2.4b +396.44%
$3.7b +55.70%
$4.5b +21.91%
$7.1b +57.31%
$6.9b -1.95%
$5.7b -17.45%
$13.4b +134.18%
$6.5b -51.32%
$5.4b -16.85%
Net Income (Loss) Attributable to Parent $1.4b
$477.0m -65.93%
$2.4b +396.44%
$3.7b +55.70%
$4.5b +21.91%
$7.1b +57.31%
$6.9b -1.95%
$5.7b -17.45%
$13.4b +134.18%
$6.5b -51.32%
$5.4b -16.85%
Net Income (Loss) Available to Common Stockholders, Basic $1.4b
$468.0m -66.40%
$2.4b +402.78%
$3.7b +55.80%
$4.5b +22.01%
$7.0b +57.43%
$6.9b -1.95%
$5.7b -17.44%
$13.4b +134.19%
$6.5b -51.31%
$5.4b -16.54%
Earnings Per Share, Basic $0.94 $0.27 $1.34 $2.07 $2.52 $3.97 $3.94 $3.28 $7.67 $3.73 $3.10
Earnings Per Share, Diluted $0.94 $0.27 $1.33 $2.06 $2.50 $3.94 $3.91 $3.26 $7.64 $3.72 $3.09
Income (Loss) from Continuing Operations, Per Basic Share $1 $0 $1 $2 $3 $4 $4 $3 $8 $4 —
Income (Loss) from Continuing Operations, Per Diluted Share $1 $0 $1 $2 $2 $4 $4 $3 $8 $4 —
Common Stock, Dividends, Per Share, Declared $1.04 $1.06 $1.34 $2.07 $2.52 $3.97 $3.94 $3.28 $2.24 $2.40 —
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b —
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b —
Dilutive Common Stock Options (in shares) $6.0m $9.0m $12.0m $13.0m $13.0m $14.0m $11.0m $9.0m $8.0m $7.0m —
Weighted Average Number of Shares Outstanding, Basic 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b 1.7b
Weighted Average Number of Shares Outstanding, Diluted 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b 1.7b
Additional Financial Items
Costs and Expenses $17.7b $25.7b $26.9b $27.4b $29.3b $34.6b $35.3b $33.6b $35.1b $36.3b —
Goodwill, Impairment Loss $0 — — — $0 $0 $0 $0 $0 $0 —
Net foreign exchange (gain) loss $495.0m ($34.0m) $28.0m $7.0m ($8.0m) $1.0m $2.0m $41.0m ($27.0m) ($50.0m) —
Operating Earnings $3.2b
$1.7b -45.81%
$3.6b +111.47%
$4.5b +24.16%
$5.4b +18.20%
$8.4b +57.27%
$8.4b -0.75%
$6.5b -22.53%
$6.8b +5.36%
$8.1b +17.99%
—
Other (income) expense, net $945.0m ($1.3b) ($139.0m) ($191.0m) ($103.0m) ($277.0m) ($321.0m) ($479.0m) ($376.0m) ($548.0m) $618.0m
Taxes on Earnings $350.0m $1.9b $539.0m $390.0m $497.0m $1.1b $1.4b $941.0m ($6.4b) $1.9b —
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax $321.0m $124.0m $34.0m — — — — — — — —
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $1.1b $353.0m $2.3b $3.7b $4.5b $7.1b $6.9b — — — —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $337.0m $124.0m $34.0m — $24.0m — $0 — — — —
Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component — — — — — — $406.0m $498.0m $542.0m $590.0m —
Total Operating Cost and Expenses $17.7b $25.7b $26.9b $27.4b $29.3b $34.6b $35.3b $33.6b $35.1b $36.3b —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.